Psychedelic Lived Experiences Summit Bridging Science & Lived Expertise 3K+ Attendees · 74 Countries 54 Interviews · 9 Panels Watch the Recordings: linktr.ee/psych.lived.exphttps://bsky.app/profile/psych-lived-exp.bsky.socialhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mmckvrdswc2zToday is International Clinical Trials Day. Clinical research depends on participants, not just protocols. Beyond data, they contribute time, trust, vulnerability and lived insight. To all clinical trial participants and those working to improve them: thank you. #ClinicalTrialsDay20 May 2026 18:46 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mmckvrdswc2zhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mkpuaw4l7c2aWhat Participant Screening Really Felt Like in an MDMA Therapy for PTSD Trial Ron reflects on the emotional and physical toll of screening and clinical questionnaires, even when the goal is to understand and validate what someone has been through. #MDMATherapy #PTSD #Psychedelics #MDMA30 Apr 2026 14:48 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mkpuaw4l7c2ahttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mknfhgcd3c2qWhat participants live through is often treated as anecdotal, when in reality it can reveal exactly what formal systems fail to capture. That is not noise. That is part of the signal. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #LivedExperience #ClinicalTrials29 Apr 2026 15:18 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mknfhgcd3c2qhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mjzjd2ksbk2zThe Philosophical Foundations of Lived and Living Experience in Psychedelic Therapy Meet @tehseennoorani.bsky.social, PhD, social scientist and facilitator of the Reimagining Psychedelic Trials working group. #PsychedelicTherapy #PsychedelicResearch #Psychedelics #LivedExperience21 Apr 2026 17:33 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mjzjd2ksbk2zhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mjpi5kwo2226The ride is never what the outside world sees. A nod to Dr. Albert Hofmann and his famous bicycle ride on April 19, 1943. History can tell us what happened. Lived experience tells us what it was like. #BicycleDay #AlbertHofmann #Psychedelics #LivedExperience17 Apr 2026 17:46 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mjpi5kwo2226https://bsky.app/profile/psych-lived-exp.bsky.social/post/3mjhuiqfstc2vWhat Mattered More Than Getting the Medicine or Placebo Meet Elizabeth Lamphere, a clinical trial participant who received placebo in an MDMA-assisted therapy study for PTSD. #MDMATherapy #PsychedelicResearch #ClinicalTrials #Placebo #PTSD14 Apr 2026 17:06 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mjhuiqfstc2vhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mjfegyx5os2vA 2017 qualitative psilocybin study by Dr Rosalind Watts found participants describing changes not only in symptoms, but in connectedness and acceptance. A useful reminder that lived experience can reveal forms of change standard outcome measures may miss. #Psilocybin #Depression #LivedExperience13 Apr 2026 17:13 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mjfegyx5os2vhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mj3efxrfs22zWhy Lived Experience Matters in Psychedelic Professional Training Meet Monnica Williams, PhD, @drmonnica.bsky.social clinical psychologist, researcher, and professor in the School of Psychology at the University of Ottawa. #PsychedelicTherapy #PsychedelicResearch #TherapistTraining #Psychedelics09 Apr 2026 17:46 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mj3efxrfs22zhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3miysn35n7k2bInformed consent matters. But it is not the same as safety. A person can be fully informed on paper and still be unprepared for what participation or treatment actually feels like. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #LivedExperience #ClinicalTrials08 Apr 2026 17:22 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3miysn35n7k2bhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3miw6ffsoxc2qHow a Dedicated Care Team Can Make Participants Feel Safer Meet Becca Kacanda, @beccakacanda.bsky.social a trial participant in MDMA-assisted therapy for PTSD. She shares how the care she received felt different from standard therapy. #PsychedelicResearch #PatientSafety #ClinicalTrials07 Apr 2026 16:15 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3miw6ffsoxc2qhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mitraq3mws2cAre you a clinician, therapist, researcher, QA, program lead, or study staff? Discover how to leverage lived experience as quality and safety infrastructure in psychedelic care. 🗓 Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC (19:00 Central Europe) #psychedelics #PatientSafety #LivedExperience06 Apr 2026 17:14 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mitraq3mws2chttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mijnfqodfc2aWhat Makes a Competent Psychedelic Therapist Beyond Degrees Meet Matthew Johnson, PhD, psychedelic researcher, experimental psychologist, senior investigator, and professor at Johns Hopkins University. #Psychedelics #PsychedelicResearch #PatientCenteredCare02 Apr 2026 16:39 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mijnfqodfc2ahttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mih5lnelwc2aLived experience is not only about sharing stories. It can reveal blind spots, improve quality and safety, and lead to better decisions in research and care. The question is whether the field is willing to treat it as expertise, not just perspective. #Psychedelics #LivedExperience #ClinicalTrials01 Apr 2026 16:50 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mih5lnelwc2ahttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3miejfhfz4226What Placebo Can Cost Participants in Prolonged Crossover Trials Meet Kathy Neustadt, a clinical trial participant who received placebo in an MDMA-assisted therapy research for PTSD. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #ClinicalTrials #placeboeffect31 Mar 2026 15:44 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3miejfhfz4226https://bsky.app/profile/psych-lived-exp.bsky.social/post/3mic3dijiy226Lived experience may be welcomed into the conversation, but rarely trusted with real authority. That gap matters. Because inclusion is not the same as influence, and consultation is not the same as shared decision-making. #Psychedelics #LivedExperienceExpertise #ClinicalTrials30 Mar 2026 16:27 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mic3dijiy226https://bsky.app/profile/psych-lived-exp.bsky.social/post/3mi7ssz5d7k26Upcoming workshop: Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC (19:00 Central Europe) Discover how to leverage lived experience as quality and safety infrastructure in psychedelic care. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #LivedExperience #ClinicalTrials29 Mar 2026 18:49 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mi7ssz5d7k26https://bsky.app/profile/psych-lived-exp.bsky.social/post/3mi2kmgnxfs2eIn 2023, the FDA issued draft guidance on clinical investigations for psychedelic drugs. The document says it is meant to give sponsors general considerations for developing psychedelic drugs for medical conditions, including trial conduct, data collection, and subject safety. #Psychedelics #FDA27 Mar 2026 16:39 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mi2kmgnxfs2ehttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhy5nkihds2eWhen Lived Experience Is Shared on Stage, Safety Matters Meet Joost Breeksema, PhD, a qualitative researcher in psychedelic trials and Executive Director of the OPEN Foundation in the Netherlands, which organizes the ICPR conference (June 4-6, 2026). #Psychedelics #PsychedelicResearch26 Mar 2026 17:42 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhy5nkihds2ehttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhvindqn5223In psychedelic care, safety is often about the dosing day. If we want a more honest standard, safety cannot mean only “nothing visibly went wrong during treatment.” It has to include what happens after, when real life resumes. #PsychedelicResearch #PatientSafety #ClinicalTrials #Psychedelics25 Mar 2026 16:20 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhvindqn5223https://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhsy7rxsjs2fPsilocybin Therapy for Anxiety: Building Safety and Trust Before Dosing Leonie reflects on what helped her feel safe entering the trial and what built trust before dosing. She shares how preparation played an important role in creating a greater sense of safety. #Psychedelics #Psilocybin24 Mar 2026 16:21 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhsy7rxsjs2fhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhqjxusfok2qIn psychedelic care, safety is often framed around screening, dosing, supervision, and acute adverse events. Those matter. But they are not the whole picture. If safety only means “nothing visibly went wrong in the room,” the standard is too low. #Psychedelics #PatientSafety23 Mar 2026 17:01 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhqjxusfok2qhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhnxfgtm622qJoining this workshop? Lived Experience as Quality and Safety Infrastructure in Psychedelic Care 🗓 Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC If you’re a clinician/therapist, researcher, QA, program lead, or study staff, this is for you. #PsychedelicTherapy #PsychedelicResearch #Psychedelics22 Mar 2026 16:23 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhnxfgtm622qhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhiu352bgs2qEligibility criteria are necessary. They help ensure safety, consistency, and rigor in research. But they also simplify. People don’t arrive as clean variables. They arrive with overlapping histories, contexts, and contradictions. #PsychedelicResearch #PatientCenteredCare #Psychedelics20 Mar 2026 15:40 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhiu352bgs2qhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhgfjid3f22vWhy Individual Treatment May Not Be Enough in Psychedelic Care Meet Chris Stauffer, MD, psychiatrist, addiction medicine specialist, and investigator of group MDMA therapy for veterans with PTSD. #PsychedelicTherapy #PsychedelicResearch #PeerSupport #LivedExperience #MDMAtherapy19 Mar 2026 16:15 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhgfjid3f22vhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhdukwjbuk2kLive workshop — Apr 11, 2026. Lived Experience as Quality and Safety Infrastructure in Psychedelic Care Frameworks + checklist to integrate lived experience into research and care (without tokenism). No Professional Pass yet? Get one to join. Link in bio. #psychedelics #PatientSafety18 Mar 2026 16:06 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhdukwjbuk2khttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mhbfd35ljk2nWhat Being Taken Off the Clinical Trial Really Felt Like Meet Kerrilee Barrett, a mental health practitioner who participated in a clinical trial involving a psychoactive substance for PTSD. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #Psychedelics17 Mar 2026 16:28 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mhbfd35ljk2nhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mgxaj2dkps2cFor decades, mental health innovation has claimed to include the voices of people with lived experience. But how much influence do those voices actually have? Paper: mental.jmir.org/2023/1/e46590 #MentalHealthResearch #PatientCenteredCare #LivedExperience #MentalHealthInnovation13 Mar 2026 15:35 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mgxaj2dkps2chttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mgus3kgx7s2nIbogaine Care and Why Lived Experience Matters Meet Jonathan Dickinson, a psychologist, renowned Ibogaine expert, published researcher, and CEO & co-founder at Ambio Life Sciences. #PsychedelicTherapy #PsychedelicResearch #LivedExperience #Ibogaine #Iboga #Psychedelics12 Mar 2026 16:11 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mgus3kgx7s2nhttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mgs7xa2wj22kPsychedelic clinical trials often focus on symptom reduction. That matters, but it is not the full story. A participant can look improved on a clinical scale while still struggling with stability, relationships, meaning-making, or life after the protocol ends. #PsychedelicResearch #ClinicalTrials11 Mar 2026 15:42 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mgs7xa2wj22khttps://bsky.app/profile/psych-lived-exp.bsky.social/post/3mgpohu4ndc2kHow Psilocybin Therapy Changed the Way I Process Emotions Meet Daryna Skybina, MPS who participated in a clinical trial studying psilocybin-assisted therapy for people with advanced cancer. #PsychedelicTherapy #PsychedelicResearch #LivedExperience #CancerResearch #PatientVoices #Psychedelics10 Mar 2026 15:23 +0000at://did:plc:hndctqjm5ukbpbh22kskstja/app.bsky.feed.post/3mgpohu4ndc2k